How accurate are testosterone tests? Generally considered adequate for clinical evaluation when the sample is drawn correctly, confirmed on a second morning, and analyzed by a standardized assay. They aren't perfect. Three problems stack on top of one another: method bias between assay types, calibration differences between laboratories, and biological variation within the same person from day to day. A single unconfirmed result from an uncertified lab can read anywhere from 45 to 365 ng/dL on the same blood sample, according to data cited in the Endocrine Society's 2018 clinical practice guideline (Bhasin et al., 2018). For men exploring hormone blood testing or reviewing their testosterone panels, understanding these sources of variation matters more than the number on any single report.

Testosterone blood tests measure hormone levels in a serum sample. The Endocrine Society recommends fasting morning total testosterone measured by a CDC-certified assay, confirmed on a second morning draw before diagnosis. About 30% of men with an initial low result have a normal level on repeat testing (Bhasin et al., 2018).

What Is a Testosterone Test?

A testosterone test is a blood test that measures the concentration of testosterone in serum. Testosterone exists in 2 forms in circulation: free (unbound) and bound (attached to proteins like sex hormone-binding globulin, or SHBG, and albumin). Most circulating testosterone is bound. A small fraction, often estimated around 2-3%, circulates as free testosterone, though this varies by individual.

Three types of testosterone measurement are available:

• Total testosterone captures both free and bound forms and is the standard first-line test.

• Free testosterone measures only the unbound fraction.

• Bioavailable testosterone measures free testosterone plus the portion loosely bound to albumin.

The American Urological Association (AUA) and the Endocrine Society both recommend starting with total testosterone (Mulhall et al., 2018). Free testosterone measurement is added when conditions that alter SHBG make total testosterone misleading, a point covered in the section on SHBG below.

How Accurate Are Testosterone Tests by Different Methods?

The laboratory method used to measure testosterone is one of the largest single sources of error. Two broad categories of assays exist: immunoassays and liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Immunoassays are automated, fast, and widely available in hospital and commercial laboratories. LC-MS/MS is slower and more expensive but provides higher specificity, sensitivity, and precision, especially at low concentrations (Bhasin et al., 2018). Uncertified immunoassay platforms can show substantial negative bias against LC-MS/MS, and some overestimate at very low concentrations where diagnostic decisions are made (Bhasin et al., 2018).

Not every immunoassay performs poorly, though. The CDC's Hormone Standardization (HoSt) program certifies assays that maintain mean bias within +/-6.4% of the reference measurement procedure across 2.50-1,000 ng/dL (CDC, 2023). Some immunoassay platforms have met this standard across multiple certification cycles. When a client orders a testosterone test by LC-MS/MS, the result is measured on the gold-standard platform. But a CDC-certified immunoassay may be considered adequate for adult-male ranges in many clinical settings.

Where accuracy collapses: uncertified assay platforms, very low concentrations approaching the diagnostic floor, and any "direct" free testosterone immunoassay.

Why Do Results Differ Between Labs?

Same blood, different numbers. That's the core problem.

When 1,133 laboratories using 14 different assays measured the same quality-control sample from a single hypogonadal man, reported values ranged from 45 to 365 ng/dL (Bhasin et al., 2018). That range spans from clearly deficient to solidly normal on a single blood sample.

The reason comes down to calibration. Each manufacturer calibrates its assay against its own reference standard. Without alignment to a common standard (like the CDC reference method), two labs running the same blood through different platforms can return results that are hundreds of ng/dL apart. Much of the inter-cohort spread observed in population studies has been traced to assay calibration differences, not biological differences between the men tested (Travison et al., 2017).

This is why both the AUA and the Endocrine Society recommend using the same laboratory and the same assay method for serial measurements (Mulhall et al., 2018). Switching labs between a first draw and a confirmation draw introduces a variable that has nothing to do with the individual's biology. When clients order individual biomarkers or pre-built lab panels from Marek Diagnostics, repeat draws use the same assay platform.

Timing, Fasting, and Day-to-Day Variation

Even a well-standardized assay will return different numbers on different days from the same person.

Testosterone follows a circadian rhythm. In studied populations of men aged 30-40, afternoon levels were approximately 20-25% lower than early-morning levels, though individual variation occurs (Bhasin et al., 2018). The gap narrows with age but doesn't disappear. A man whose afternoon result falls below 300 ng/dL may have a morning value well within the reference range. Both the AUA and the Endocrine Society require early-morning draws (before 10 AM) for this reason.

Food matters too. Total testosterone may drop considerably after eating, with some studies reporting decreases of 30% or more depending on meal composition (Bhasin et al., 2018). Guidelines specify fasting for this reason.

Beyond timing and food, inherent biological variation adds another layer. Research on intraindividual testosterone variability found that 2 measurements on the same man may differ by 18-28% or more, depending on individual biological variation (Brambilla et al., 2007). A clinician can expect bounce. That's normal physiology, not lab error.

One fasting morning draw tells a limited story. A confirmed second draw, at the same time, same lab, and same fasting state, is the minimum the guidelines require before making clinical decisions.

Total Testosterone vs Free Testosterone

Total testosterone is the right starting point for most men. It's the measurement both major U.S. guidelines base their diagnostic thresholds on.

But total testosterone can be misleading when SHBG is abnormally high or low. SHBG rises with aging, liver disease, HIV, hyperthyroidism, and certain medications like anticonvulsants. When SHBG is high, more testosterone gets bound, and a man can have a "normal" total testosterone while his free, biologically active fraction is low.

The reverse happens with obesity, type 2 diabetes, hypothyroidism, and glucocorticoid use. These conditions push SHBG down, pulling total testosterone lower while free testosterone may remain adequate. The Endocrine Society lists these SHBG-altering conditions in Table 2 of its guideline, specifically flagging them as situations where free testosterone should be measured (Bhasin et al., 2018).

One point to flag on free testosterone measurement: the Endocrine Society's 2018 guideline states that analog "direct" free testosterone immunoassays are inaccurate and recommends against their use. The recommended methods are equilibrium dialysis or a validated calculation from accurately measured total testosterone, SHBG, and albumin. Marek Diagnostics offers free testosterone by dialysis paired with LC-MS/MS total testosterone, which aligns with the method the Endocrine Society guideline recommends.

Diagnostic Cutoffs Across Clinical Guidelines

There isn't a single number that defines "low" testosterone. Different guidelines use different thresholds, and different assays produce different reference ranges.

The Travison et al. (2017) harmonized reference study combined 4 cohorts (9,054 men), cross-calibrated all results to the CDC reference method, and established the 2.5th percentile in healthy, nonobese men aged 19-39 at 264 ng/dL. The full harmonized range was 264-916 ng/dL (Travison et al., 2017). The Endocrine Society adopted this as the lower reference limit for CDC-certified assays (Bhasin et al., 2018).

The AUA uses 300 ng/dL as a "reasonable cut-off" (Moderate Recommendation, Evidence Level Grade B) (Mulhall et al., 2018).

UK biochemical guidance from Jayasena et al. (2023) uses a 3-tier system: below 8 nmol/L (about 231 ng/dL) is likely deficiency, 8-12 nmol/L (about 231-346 ng/dL) requires clinical correlation, and above 12 nmol/L (about 346 ng/dL) is generally not consistent with hypogonadism (Jayasena et al., 2023).

A man at 280 ng/dL can fall on different sides of the diagnostic line depending on which guideline his provider follows. Below is a comparison:

These thresholds are population-level guideline recommendations. Whether a specific level warrants further evaluation depends on symptoms, clinical history, and a provider's assessment.

None of these thresholds stands alone. All 3 guidelines require symptoms plus confirmed low levels on at least 2 separate morning draws before diagnosis.

Are At-Home Testosterone Tests Reliable?

At-home testosterone kits are widely available, but they carry accuracy limitations that clinical laboratory draws don't.

Saliva-based tests measure only free testosterone, not total. Because diagnostic guidelines are based on total testosterone, a saliva result alone can't confirm or rule out deficiency. Blood-based finger-prick tests collect smaller sample volumes and tend to produce more variable results than venous draws.

Blood lancet devices that draw from the upper arm tend to produce more consistent results closer to venous blood. But at-home kits are generally considered screening tools rather than diagnostic endpoints by current guideline standards. The AUA's guideline requires 2 early-morning draws analyzed by a certified laboratory (Mulhall et al., 2018). A single at-home result doesn't meet that standard.

For men who want screening before committing to a full lab visit, an at-home test can provide a directional signal. But a confirmed diagnosis still requires venous blood, morning timing, fasting, and a certified assay. A structured lab panel such as a pre-TRT lab panel drawn through a standardized laboratory network can serve as a starting point for clinical evaluation.

Next Steps After an Abnormal Result

About 30% of men with an initial total testosterone in the deficient range have a normal value on repeat testing (Bhasin et al., 2018). That single statistic is the strongest argument for the 2-test requirement.

When a second fasting morning draw confirms a low total testosterone, providers typically work to determine the underlying cause. The AUA recommends measuring luteinizing hormone (LH) to distinguish primary hypogonadism (a testicular problem, where LH is elevated) from secondary hypogonadism (a pituitary or hypothalamic problem, where LH is low or inappropriately normal). If LH is low or low-normal, prolactin should be checked to rule out a pituitary cause (Mulhall et al., 2018).

Marek Diagnostics includes LH and FSH testing and prolactin levels as standalone tests or as part of broader panels. Adding sensitive estradiol and a complete blood count (for hematocrit) rounds out the baseline safety workup that guidelines recommend before any treatment decision.

An abnormal result isn't a diagnosis by itself. It's one data point that may or may not hold up on a second draw, and it requires clinical evaluation before any treatment path begins.

How to Get the Most Accurate Testosterone Test

Accuracy starts with test conditions, not the test itself. A result drawn at 3 PM after lunch through an uncertified lab immunoassay may not reflect an individual's actual baseline and shouldn't be treated as definitive.

The protocol that produces reliable results: fast overnight, draw blood before 10 AM, use a CDC-certified assay (or LC-MS/MS), and confirm with a second draw 1-3 weeks later at the same lab using the same method. If SHBG-altering conditions are present (obesity, type 2 diabetes, liver disease, thyroid dysfunction), add SHBG testing and calculated or dialysis-based free testosterone.

"Analog" or "direct" free testosterone on a standard lab panel should be disregarded. If a lab menu offers this test, it isn't the measurement the Endocrine Society guideline calls for.

For men asking how accurate are testosterone tests in their own case, the answer depends on whether the sample was collected, timed, and analyzed correctly. Any testing decision should be made in consultation with a qualified healthcare provider who can account for individual health history and circumstances. When those conditions are met, the test is reliable enough to support clinical decisions. When they aren't, a result that looks low may mean nothing, and a result that appears normal may not tell the full story if SHBG or timing factors weren't accounted for.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

How accurate are testosterone tests from a standard laboratory?

Testosterone tests are accurate enough for clinical use when the sample is drawn under the right conditions (fasting, morning, same lab). Certified assays under the CDC's HoSt program must maintain mean bias within +/-6.4% of the reference method. Without certification, lab-to-lab variability can produce results ranging from 45 to 365 ng/dL on the same sample, based on data cited in the Endocrine Society's 2018 guideline (Bhasin et al., 2018).

Do testosterone levels change based on the time of day?

Yes. Testosterone follows a circadian rhythm, peaking in the early morning. In men aged 30-40, afternoon levels run 20-25% lower than 8 AM levels. Both the AUA and the Endocrine Society require early-morning draws (before 10 AM) because reference ranges were built on morning samples (Bhasin et al., 2018; Mulhall et al., 2018).

Why did my testosterone level change between two different labs?

Different laboratories use different assay platforms with different calibrations. A quality-control study cited in the Endocrine Society 2018 guideline found that 1,133 labs using 14 assays returned values from 45 to 365 ng/dL on the same blood sample (Bhasin et al., 2018). Both major U.S. guidelines recommend using the same lab and method for serial measurements to remove this variable (Mulhall et al., 2018).

Is free testosterone more accurate than total testosterone?

Total testosterone is the recommended starting test per both U.S. guidelines. Free testosterone should be added when conditions that alter SHBG (obesity, type 2 diabetes, liver disease, aging, thyroid disorders) make total testosterone misleading. The method of free testosterone measurement matters: analog "direct" free testosterone immunoassays are inaccurate, and the Endocrine Society recommends equilibrium dialysis or a validated calculation instead (Bhasin et al., 2018).

How accurate are at-home testosterone tests compared to lab draws?

At-home tests vary in reliability depending on the collection method. Saliva tests measure only free testosterone, not total, so they can't confirm deficiency under current guidelines. Finger-prick blood tests produce more variable results than venous draws. Blood lancet devices that collect from the upper arm tend to produce results closer to venous samples. No at-home test replaces the 2-draw, fasting morning protocol that guidelines require for diagnosis (Mulhall et al., 2018).

How many testosterone tests are needed before a diagnosis?

At least 2. About 30% of men with an initial total testosterone in the deficient range have a normal value on a second draw, according to the Endocrine Society 2018 guideline (Bhasin et al., 2018). Both the AUA and the Endocrine Society require 2 separate early-morning, fasting draws on different days before confirming a diagnosis of testosterone deficiency.

References

• Ann Clin Biochem. 2023. doi: 10.1177/00045632231179022.

• CDC Clinical Standardization Programs. Hormone Standardization (HoSt).

• Clin Endocrinol (Oxf). 2007;67:853-862.

• J Clin Endocrinol Metab. 2017;102(4):1161-1173.

• J Clin Endocrinol Metab. 2018;103(5):1715-1744.

• J Urol. 2018;200(2):423-432.